News Detail
Copenhagen, 9 Dec 2020: Cancer patients who took immune therapies such as Merck & Co.’s Keytruda or Bristol-Myers Squibb Co.’s Opdivo showed a greater risk of developing heart problems in a View Details
Source : Hindustan Times
Related News
- Which masks give you the best protection? (13-12-2020)
- Non-Contact Thermometers (Infrared Guns) Miss 5 Out of 6 Fevers: Reveals Study (12-12-2020)
- Scientists develop new inhalation delivery system for vaccines (11-12-2020)
- Molnupiravir blocks SARS-CoV-2 transmission, researchers find (06-12-2020)
- Scientists develop novel method to detect single virus particles (28-11-2020)
- Covid-19 virus may hijack our cells' cholesterol system to spread through body, says study (27-11-2020)
- Green tea, pomegranate juice and other herbs inhibit Covid-19: Study (14-11-2020)
- Cloth masks highly preventive against Covid-19, says new CDC study (14-11-2020)
- Covid face masks can trigger skin allergies: Study (14-11-2020)
- Scientists develop novel method to preserve vaccines without refrigeration (13-11-2020)